# National Heart, Lung, and Blood Institute

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/national-heart-lung-and-blood-institute/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | research institute part of U.S. National Institutes of Health (NIH) |
| OpenAlex ID | https://openalex.org/F4320337338 |
| ROR ID | https://ror.org/012pb6c26 |
| Works | 480,156 |

## Funder papers

Showing 15 of 55.

- [Effects of Intensive Glucose Lowering in Type 2 Diabetes](https://scholariq.org/papers/effects-of-intensive-glucose-lowering-in-type-2-diabetes/)
- [Development and Validation of the American Heart Association’s PREVENT Equations](https://scholariq.org/papers/development-and-validation-of-the-american-heart-association-s-prevent-equations/)
- [Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome](https://scholariq.org/papers/ultrafiltration-in-decompensated-heart-failure-with-cardiorenal-syndrome/)
- [Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: systematic review, meta-analysis, and dose-response of 61 controlled intervention trials](https://scholariq.org/papers/effects-of-tree-nuts-on-blood-lipids-apolipoproteins-and-blood-pressure/)
- [A healthy approach to dietary fats: understanding the science and taking action to reduce consumer confusion](https://scholariq.org/papers/a-healthy-approach-to-dietary-fats-understanding-the-science-and-taking-action/)
- [Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study](https://scholariq.org/papers/inflammatory-risk-and-cardiovascular-events-in-patients-without-obstructive/)
- [Ambient air pollution and clinical dementia: systematic review and meta-analysis](https://scholariq.org/papers/ambient-air-pollution-and-clinical-dementia-systematic-review-and-meta-analysis-2/)
- [Feasibility and Quit Rates of the Tobacco Status Project: A Facebook Smoking Cessation Intervention for Young Adults](https://scholariq.org/papers/feasibility-and-quit-rates-of-the-tobacco-status-project-a-facebook-smoking/)
- [Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF](https://scholariq.org/papers/initial-decline-dip-in-estimated-glomerular-filtration-rate-after-initiation-of/)
- [The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study](https://scholariq.org/papers/the-mslt-is-repeatable-in-narcolepsy-type-1-but-not-narcolepsy-type-2-a/)
- [Cardiac Resynchronization Therapy Improves Renal Function in Human Heart Failure With Reduced Glomerular Filtration Rate](https://scholariq.org/papers/cardiac-resynchronization-therapy-improves-renal-function-in-human-heart-failure/)
- [Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease](https://scholariq.org/papers/efficacy-and-safety-of-spironolactone-in-patients-with-hfpef-and-chronic-kidney/)
- [Effectiveness of Digoxin in Reducing One-Year Mortality in Chronic Heart Failure in the Digitalis Investigation Group Trial](https://scholariq.org/papers/effectiveness-of-digoxin-in-reducing-one-year-mortality-in-chronic-heart-failure/)
- [Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: Insights from the SOLVD Treatment trial](https://scholariq.org/papers/effects-of-enalapril-in-systolic-heart-failure-patients-with-and-without-chronic/)
- [Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial](https://scholariq.org/papers/vericiguat-in-patients-with-chronic-heart-failure-and-reduced-ejection-fraction/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.